DRD2 and Parkinson disease: Fujimori et al. showed how the treatment with Ropinirole (Figure 10, panel A), an agonist for receptors D2R, D3R, and D4R mainly used for Parkinson’s disease, has neuroprotective effects in ALS models [54].